ClearPoint Neuro, Inc. (CLPT) shareholders
Close on Nov 18, 2026Market cap $247.14MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bigger Michael Joint filing with Bigger Capital Fund L P (5.33%), Bigger Capital Fund GP, LLC (5.33%) | 2,601,255 | 8.12% | 13G (passive) amendment | Sep 30, 2026 |
| Mak Capital One LLC Joint filing with MAK Capital Fund LP (7.80%), Kaufman Michael A (7.80%) | 2,375,861 | 7.80% | 13G (passive) amendment | Jun 30, 2026 |
| BlackRock, Inc. | 2,118,912 | 7.10% | 13G (passive) amendment | Jun 30, 2026 |
| Michael Bigger | 2,045,921 | 7.40% | 13G (passive) amendment | Sep 30, 2024 |
| Kaufman Michael A Joint filing with MAK Capital Fund LP (6.10%), Mak Capital One LLC (6.10%) | 1,729,611 | 6.10% | 13G (passive) | Mar 10, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CLPT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,379,804 | 7.42% | $42.46M | +297,054 | 0.00% |
| Mak Capital One LLC | 2,375,861 | 7.41% | $42.39M | +474,372 | 5.94% |
| Vanguard Capital Management LLC | 1,232,807 | 3.85% | $21.99M | −10,808 | 0.00% |
| State Street Corp | 816,547 | 2.55% | $14.57M | +136,728 | 0.00% |
| Geode Capital Management, LLC | 749,932 | 2.34% | $13.38M | +44,212 | 0.00% |
| Lane Generational LLC | 444,831 | 1.39% | $7.94M | −42,018 | 6.97% |
| UBS Group AG | 428,632 | 1.34% | $7.65M | −3,728 | 0.00% |
| Millennium Management LLC | 357,676 | 1.12% | $6.38M | +125,702 | 0.00% |
| Brown Advisory Inc | 325,906 | 1.02% | $5.81M | – | 0.01% |
| Compass Financial Management LLC | 295,680 | 0.92% | $5.27M | New | 0.64% |
| Susquehanna International Group, Llp | 240,282 | 0.75% | $4.29M | +103,998 | 0.00% |
| Northern Trust Corp | 230,986 | 0.72% | $4.12M | +21,560 | 0.00% |
| Pier Capital, LLC | 222,761 | 0.69% | $3.97M | New | 0.53% |
| Vanguard Fiduciary Trust Co | 213,246 | 0.67% | $3.80M | +7,491 | 0.00% |
| Vanguard Portfolio Management LLC | 194,584 | 0.61% | $3.47M | −90,225 | 0.00% |
| Tudor Investment Corp Et Al | 173,759 | 0.54% | $3.10M | +16,788 | 0.00% |
| Morgan Stanley | 165,786 | 0.52% | $2.96M | +35,914 | 0.00% |
| Two Sigma Investments, LP | 154,851 | 0.48% | $2.76M | −55,929 | 0.00% |
| Bank of New York Mellon Corp | 151,767 | 0.47% | $2.71M | +8,020 | 0.00% |
| Parsons Capital Management Inc/Ri | 148,976 | 0.46% | $2.66M | −194 | 0.12% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 129 | 14M | 43.4% | 23 / 46 | 30 / 11 | 2M | 2M |
| Q1 2026 | 118 | 13M | 40.5% | 28 / 43 | 20 / 25 | 5M | 2M |
| Q4 2025 | 118 | 11M | 35.3% | 26 / 31 | 34 / 14 | 3M | 2M |
| Q3 2025 | 107 | 10M | 31.2% | 26 / 30 | 27 / 15 | 2M | 2M |
| Q2 2025 | 96 | 9M | 28.6% | 27 / 36 | 16 / 31 | 4M | 2M |
| Q1 2025 | 101 | 8M | 25.6% | 23 / 29 | 31 / 11 | 2M | 1M |
| Q4 2024 | 89 | 8M | 23.7% | 22 / 24 | 18 / 11 | 2M | 1M |
| Q3 2024 | 78 | 7M | 21.3% | 15 / 20 | 21 / 22 | 2M | 1M |
| Q2 2024 | 86 | 7M | 22.0% | 22 / 19 | 21 / 17 | 2M | 3M |
| Q1 2024 | 81 | 8M | 24.5% | 17 / 23 | 20 / 7 | 2M | 0M |
| Q4 2023 | 71 | 6M | 20.2% | 14 / 19 | 17 / 6 | 1M | 0M |
| Q3 2023 | 63 | 6M | 18.5% | 12 / 16 | 12 / 8 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
98 funds held CLPT in Q2 2026, 68% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CLPT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 853,804 | 2.66% | $15.23M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 736,857 | 2.30% | $13.15M | 0.02% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 351,978 | 1.10% | $6.28M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 308,608 | 0.96% | $4.61M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 264,730 | 0.83% | $4.72M | 0.03% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 154,615 | 0.48% | $1.96M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 142,244 | 0.44% | $1.80M | 0.01% | May 31, 2026 |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | 122,955 | 0.38% | $2.19M | 0.08% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 94,770 | 0.30% | $1.69M | 0.11% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF | 90,078 | 0.28% | $1.61M | 1.06% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 68,597 | 0.21% | $1.02M | 0.01% | Jul 31, 2026 |
| DWS Global Small Cap Fund | 59,542 | 0.19% | $889.56K | 0.44% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 53,803 | 0.17% | $681.68K | 0.00% | May 31, 2026 |
| Master Small Cap Index Series | 52,695 | 0.16% | $940.08K | 0.02% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 45,291 | 0.14% | $573.84K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joseph Burnett | CEO and President, Director | 322,108 | 1.00% | Sep 3, 2026 |
| L. Jeremy Stigall | Chief Business Officer | 110,263 | 0.34% | Jul 2, 2026 |
| Danilo D'Alessandro | Chief Financial Officer | 103,769 | 0.32% | Jul 2, 2026 |
| Mazin Sabra | Chief Operating Officer | 67,343 | 0.21% | Mar 16, 2026 |
| R. John Fletcher | Director | 132,004 | 0.41% | Oct 2, 2026 |
| Timothy T. Richards | Director | 87,863 | 0.27% | Oct 2, 2026 |
| Matthew B. Klein | Director | 46,935 | 0.15% | May 26, 2026 |
| Linda M. Liau | Director | 64,801 | 0.20% | May 26, 2026 |
| B. Kristine Johnson | Director | 71,116 | 0.22% | May 26, 2026 |
| Lynnette C. Fallon | Director | 48,227 | 0.15% | May 26, 2026 |
| Pascal E. R. Girin | Director | 110,623 | 0.35% | May 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Timothy T. Richards Director | Oct 1, 2026 | Award | +319 | $12.21 | $3.89K | 87,863 |
| R. John Fletcher Director | Oct 1, 2026 | Award | +993 | $12.21 | $12.12K | 132,004 |
| Joseph Burnett CEO and President, Director | Sep 2, 2026 | Option exercise | +12,517 | $3.47 | $43.43K | 130,720 |
| Timothy T. Richards Director | Jul 1, 2026 | Award | +222 | $17.84 | $3.96K | 87,544 |
| R. John Fletcher Director | Jul 1, 2026 | Award | +662 | $17.84 | $11.81K | 131,011 |
| Joseph Burnett CEO and President, Director | Jun 30, 2026 | Award | +1,361 | $11.93 | $16.24K | 118,203 |
| L. Jeremy Stigall Chief Business Officer | Jun 30, 2026 | Award | +1,781 | $11.93 | $21.25K | 110,263 |
| Danilo D'Alessandro Chief Financial Officer | Jun 30, 2026 | Award | +1,085 | $11.93 | $12.94K | 103,769 |
| Joseph Burnett CEO and President, Director | Jun 29, 2026 | Sale(10b5-1 plan) | −20,000 | $19.38 | $387.60K | 116,842 |
| Joseph Burnett CEO and President, Director | Jun 29, 2026 | Option exercise | +20,000 | $2.50 | $50.00K | 136,842 |
| Joseph Burnett CEO and President, Director | Jun 17, 2026 | Option exercise | +60,000 | $2.50 | $150.00K | 176,842 |
| Joseph Burnett CEO and President, Director | Jun 17, 2026 | Sale(10b5-1 plan) | −60,000 | $17.79 | $1.07M | 116,842 |
| Joseph Burnett CEO and President, Director | Jun 17, 2026 | Sale(10b5-1 plan) | −1,843 | $17.94 | $33.06K | 191,388 |
| Timothy T. Richards Director | Jun 4, 2026 | Option exercise | +500 | $10.00 | $5.00K | 87,698 |
| Timothy T. Richards Director | Jun 4, 2026 | Tax withholding | −376 | $13.30 | $5.00K | 87,322 |
| Timothy T. Richards Director | Jun 1, 2026 | Sale | −5,415 | $12.17 | $65.90K | 87,198 |
| Matthew B. Klein Director | May 21, 2026 | Sale | −16,000 | $11.59 | $185.44K | 46,935 |
| Lynnette C. Fallon Director | May 20, 2026 | Sale(10b5-1 plan) | −5,091 | $11.14 | $56.71K | 48,227 |
| R. John Fletcher Director | May 19, 2026 | Option exercise | +12,417 | – | – | 130,349 |
| Matthew B. Klein Director | May 19, 2026 | Option exercise | +12,417 | – | – | 62,935 |
| Timothy T. Richards Director | May 19, 2026 | Option exercise | +12,417 | – | – | 92,613 |
| Lynnette C. Fallon Director | May 19, 2026 | Option exercise | +12,417 | – | – | 53,318 |
| Pascal E. R. Girin Director | May 19, 2026 | Option exercise | +12,417 | – | – | 110,623 |
| Linda M. Liau Director | May 19, 2026 | Option exercise | +12,417 | – | – | 64,801 |
| B. Kristine Johnson Director | May 19, 2026 | Option exercise | +12,417 | – | – | 71,116 |
| Timothy T. Richards Director | Apr 1, 2026 | Award | +442 | $9.10 | $4.02K | 80,196 |
| R. John Fletcher Director | Apr 1, 2026 | Award | +1,270 | $9.10 | $11.56K | 117,932 |
| Pascal E. R. Girin Director | Apr 1, 2026 | Award | +755 | $9.10 | $6.87K | 98,206 |
| Joseph Burnett CEO and President, Director | Mar 19, 2026 | Option exercise | +20,942 | $3.24 | $67.85K | 116,842 |
| Mazin Sabra Chief Operating Officer | Mar 12, 2026 | Tax withholding | −13,281 | $11.53 | $153.13K | 67,343 |
| Mazin Sabra Chief Operating Officer | Mar 12, 2026 | Option exercise | +26,101 | – | – | 80,624 |
| Danilo D'Alessandro Chief Financial Officer | Mar 12, 2026 | Option exercise | +32,627 | – | – | 119,285 |
| Danilo D'Alessandro Chief Financial Officer | Mar 12, 2026 | Tax withholding | −16,601 | $11.53 | $191.41K | 102,684 |
| Joseph Burnett CEO and President, Director | Mar 12, 2026 | Tax withholding | −43,161 | $11.53 | $497.65K | 95,900 |
| Joseph Burnett CEO and President, Director | Mar 12, 2026 | Option exercise | +84,829 | – | – | 139,061 |
| L. Jeremy Stigall Chief Business Officer | Mar 12, 2026 | Option exercise | +30,995 | – | – | 123,633 |
| L. Jeremy Stigall Chief Business Officer | Mar 12, 2026 | Tax withholding | −15,151 | $11.53 | $174.69K | 108,482 |
| L. Jeremy Stigall Chief Business Officer | Mar 11, 2026 | Tax withholding | −3,224 | $11.62 | $37.46K | 92,638 |
| L. Jeremy Stigall Chief Business Officer | Mar 11, 2026 | Option exercise | +8,291 | – | – | 95,862 |
| Danilo D'Alessandro Chief Financial Officer | Mar 11, 2026 | Tax withholding | −2,109 | $11.62 | $24.51K | 86,658 |
| Danilo D'Alessandro Chief Financial Officer | Mar 11, 2026 | Option exercise | +4,145 | – | – | 88,767 |
| Joseph Burnett CEO and President, Director | Mar 6, 2026 | Tax withholding | −22,709 | $10.00 | $227.09K | 54,232 |
| Joseph Burnett CEO and President, Director | Mar 6, 2026 | Option exercise | +47,407 | – | – | 76,941 |
| L. Jeremy Stigall Chief Business Officer | Mar 6, 2026 | Option exercise | +17,778 | – | – | 94,484 |
| L. Jeremy Stigall Chief Business Officer | Mar 6, 2026 | Tax withholding | −6,913 | $10.00 | $69.13K | 87,571 |
| Danilo D'Alessandro Chief Financial Officer | Mar 6, 2026 | Tax withholding | −9,548 | $10.00 | $95.48K | 84,622 |
| Danilo D'Alessandro Chief Financial Officer | Mar 6, 2026 | Option exercise | +18,765 | – | – | 94,170 |
| Mazin Sabra Chief Operating Officer | Mar 6, 2026 | Tax withholding | −7,036 | $10.00 | $70.36K | 54,523 |
| Mazin Sabra Chief Operating Officer | Mar 6, 2026 | Option exercise | +13,827 | – | – | 61,559 |
| Joseph Burnett CEO and President, Director | Mar 3, 2026 | Tax withholding | −9,533 | $8.84 | $84.27K | 29,534 |
| Joseph Burnett CEO and President, Director | Mar 3, 2026 | Option exercise | +26,568 | – | – | 39,067 |
| Danilo D'Alessandro Chief Financial Officer | Mar 3, 2026 | Option exercise | +10,332 | – | – | 80,662 |
| Danilo D'Alessandro Chief Financial Officer | Mar 3, 2026 | Tax withholding | −5,257 | $8.84 | $46.47K | 75,405 |
| L. Jeremy Stigall Chief Business Officer | Mar 3, 2026 | Tax withholding | −4,506 | $8.84 | $39.83K | 76,706 |
| L. Jeremy Stigall Chief Business Officer | Mar 3, 2026 | Option exercise | +8,856 | – | – | 81,212 |
| Mazin Sabra Chief Operating Officer | Mar 3, 2026 | Tax withholding | −3,380 | $8.84 | $29.88K | 47,732 |
| Mazin Sabra Chief Operating Officer | Mar 3, 2026 | Option exercise | +6,642 | – | – | 51,112 |
| Joseph Burnett CEO and President, Director | Feb 25, 2026 | Sale(10b5-1 plan) | −19,951 | $15.17 | $302.66K | 193,231 |
| Joseph Burnett CEO and President, Director | Jan 26, 2026 | Sale(10b5-1 plan) | −2,943 | $15.57 | $45.82K | 214,116 |
| Joseph Burnett CEO and President, Director | Jan 9, 2026 | Option exercise | +20,000 | $2.50 | $50.00K | 31,565 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of ClearPoint Neuro's stock actually held short. Settlement fails (shares not delivered on time) peaked at 45,487 shares on Sep 15, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Joseph Burnett Director, Officer | Jun 29, 2026 | 20,000 | $369.60K | Jun 29, 2026 | Exercise of Stock Options |
| Joseph Burnett Director, Officer | Jun 17, 2026 | 60,000 | $800.40K | Jun 17, 2026 | Exercise of Stock Options |
| Joseph Burnett Affiliate of Director | Jun 17, 2026 | 1,843 | $24.59K | Jun 17, 2026 | Previously vested RSU |
| Timothy T. Richards Director | Jun 1, 2026 | 5,145 | $62.61K | Jun 1, 2026 | Restricted stock vesting under a registered plan |
| Pascal E. R. Girin Director | May 29, 2026 | 66,679 | $836.45K | May 29, 2026 | Stock Option Exercise |
| Matthew B. Klein Director | May 21, 2026 | 16,000 | $185.39K | May 21, 2026 | Restricted stock vesting under a registered plan |
| Lynnette C. Fallon Director | May 20, 2026 | 5,091 | $56.87K | May 20, 2026 | Restricted Stock Units |
| Joseph Burnett Affiliate of Director | Feb 25, 2026 | 21,794 | $317.10K | Feb 25, 2026 | Previously vested RSA |
| Joseph Burnett Officer, Director | Feb 20, 2026 | 20,000 | $306.20K | Jan 9, 2026 | Employee Stock Purchase Plan |
| Joseph Burnett Affiliate of Director | Jan 26, 2026 | 2,943 | $46.15K | Jan 26, 2026 | Restricted Stock Units |
| Joseph Burnett Director, Officer | Jan 9, 2026 | 20,000 | $306.20K | Jan 9, 2026 | Exercise of Stock Options |
| Joseph Burnett Affiliate of Director | Oct 10, 2025 | 26,463 | $766.37K | Oct 10, 2025 | Employee Stock Purchase Plan |
| Timothy T. Richards Director | Jun 10, 2025 | 10,000 | $132.84K | Jun 10, 2025 | Restricted stock vesting under a registered plan |
| Joseph Burnett Officer, Director | Jun 9, 2025 | 21,247 | $282.36K | Jun 9, 2025 | Restricted stock vesting under a registered plan |
| Lynnette C. Fallon Director | Jun 3, 2025 | 10,200 | $128.23K | Jun 3, 2025 | Restricted stock vesting under a registered plan |
See a number that looks wrong?